Objective: To review and summarize the dietary determinants of the metabolic syndrome, subclinical inflammation and dyslipidemia in overweight children. Design: Review of the current literature, focusing on pediatric studies. Participants: Normal weight, overweight, or obese children and adolescents. Results: There is a growing literature on the metabolic effects of excess body fat during childhood. However, few pediatric studies have examined the dietary determinants of obesity-related metabolic disturbances. From the available data, it appears that dietary factors are not only important environmental determinants of adiposity, but also may affect components of the metabolic syndrome and modulate the actions of adipokines. Dietary total fat and saturated fat are associated with insulin resistance and high blood pressure, as well as obesity-related inflammation. In contrast to studies in adults, resistin and adiponectin do not appear to be closely linked to insulin resistance or dyslipidemia in childhood. However, circulating leptin and retinol-binding protein (RBP) 4 correlate well with obesity, central obesity and the metabolic syndrome in children. Intakes of antioxidant vitamins tend to be low in obese children and may be predictors of subclinical inflammation. Higher fructose intake from sweets and sweetened drinks in overweight children has been linked to decreased low-density lipoprotein (LDL) particle size. Conclusions: Dietary interventions aimed at reducing intakes of total fat, saturated fat and free fructose, whereas increasing antioxidant vitamin intake may be beneficial in overweight children. More research on the relationships between dietary factors and the metabolic changes of pediatric obesity may help to identify the dietary changes to reduce health risks.
Introduction
In both industrialized and non-industrialized countries, the prevalence of pediatric obesity is increasing. 1 Dietary factors are environmental determinants of adiposity, as well as components of the metabolic syndrome, and may modulate the actions of adipokines. Better understanding of the relationships between dietary factors and the metabolic changes of pediatric obesity may help to identify the dietary changes to reduce health risks.
Hypertension, insulin resistance, resistin and adiponectin
Pediatric obesity is an important risk factor for adult hypertension and type 2 diabetes, and approximately one third of obese children are hypertensive and/or hyperinsulinemic. 2, 3 The adipocyte-derived hormones resistin, adiponectin and leptin may play a role in the development of hypertension and/or insulin resistance. [4] [5] [6] [7] Among children, inverse associations of adiponectin or resistin with body mass index (BMI) and insulin resistance have been reported, 8 but not all studies agree. 9 Studies on diet in childhood hypertension have mainly focused on sodium or calcium intake, rather than macronutrients. In a recent Swiss study that investigated the dietary determinants of blood pressure (BP), insulin resistance, and leptin, resistin and adiponectin concentrations, BMI, BF% and waist/hip (W/H) ratio were significant predictors of fasting leptin and insulin concentrations, quantitative insulin-sensitivity check index (QUICKI), and systolic BP (SBP), but not resistin or adiponectin concentrations. Total energy, fat, saturated fat and protein intakes were significant predictors of fasting insulin and QUICKI, and total fat, saturated fat and monounsaturated fat intakes were significant predictors of SBP, independent of BMI-SDS and age. There were no associations between these dietary factors and leptin, adiponectin or resistin. These data are generally consistent with earlier studies indicating that hypertension and hyperinsulinemia are correlated with overweight in children. 2, 10, 11 As elevated BP during childhood increases risk for adult hypertension, 12 potential dietary determinants of BP should be identified early in the disease, but few pediatric studies have produced equivocal data. 2 In pediatric studies that controlled for potential confounders (such as age, sex or BMI), some have found significant positive associations between dietary sodium and BP, whereas others have not. 13, 14 Studies in children of weight loss induced by energy restriction and exercise 15, 16 have suggested a correlation between reduced energy intake, exercise and BP. Associations between macronutrient intake and BP in children have been examined in several studies. A cohort study of 8-11-year-old children followed for 3 years found a positive correlation between total fat intake and SBP and diastolic BP. 17 In 15-18-year-old hypertensive adolescents, a diet rich in polyunsaturated fatty acids (PUFAs) was associated with a reduction in SBP and diastolic BP. 18 In contrast, adolescents who increased their dietary ratio of polyunsaturated to saturated fat from E0.6 to 1.0 did not experience a decrease in BP. 19 Polymorphisms of the resistin gene have been linked to hypertension in adults. 4 Resistin promotes the release of endothelin-1, a potent vasoconstrictor, from endothelial cells, 20 although the resistin-like molecule-a has vasoconstrictive properties. 21 The relationship between resistin, adiponectin, adiposity and insulin resistance in humans is unclear; 22 several studies in adults have found resistin or adiponectin concentrations predict insulin resistance, 8, 23 whereas others have not. 24 Several pediatric studies have not reported an association between resistin or adiponectin and weight status, leptin or insulin concentrations. 8, 25, 26 In adults, circulating leptin predictably rises after overfeeding 27 and falls after fasting. 28 However, whether specific macronutrients alter serum leptin concentrations independent of energy intake is equivocal. Studies correlating fat and carbohydrate intakes and leptin concentrations in adults have produced contradictory results. 29, 30 There are few data in children on the dietary determinants of circulating leptin. In healthy Greek adolescents (mean age 18 years), leptin concentrations showed weak negative correlations with carbohydrate intake, and weak positive associations with fat intake. 31 In a study of 5-year-old Finnish children, leptin was correlated with body weight, but not with intakes of energy, fat, saturated fat, carbohydrates, sucrose or protein. 32 In obese 7-11-year-old children, no association was found between leptin and energy, fat or carbohydrate intake. 33 Intravenous leptin in animals increases sympathetic nerve activation 34 and produces endothelium-dependent vasodilation, 35 resulting in variable effects on BP. Although several adult studies have found increased leptin concentrations are correlated with hypertension, 5 other studies have not. 36 In two earlier studies in children 37 leptin concentrations were positively correlated with BP, but after adjusting for BMI, these associations were not significant. Hyperinsulinemia has also been linked to hypertension. 38 There are several possible mechanisms by which insulin could increase BP, including increased renal sodium absorption, 39 increased sympathetic tone 40 and hypertrophy of vascular smooth muscle increasing peripheral resistance. 41 Several studies in children and adolescents have found positive correlations between fasting insulin concentrations and SBP. 42, 43 High dietary fat intake may increase insulin resistance independent of weight gain. 44 Fatty acid composition of cell membranes can be influenced by the dietary fat intake, and a high proportion of membrane-saturated fats may impair insulin action by altering insulin receptor binding/affinity, impairing translocation of glucose transporters and reducing ion permeability. 45 Several studies in adults, including both lean and obese participants, have found a total fat intake and intake of saturated fat are significant positive predictors of fasting insulin, whereas intakes of dietary fiber and starch are negative predictors. 44 However, few studies have examined associations between dietary factors and insulin sensitivity in children, and they have focused on carbohydrate and not fat intake. 46 
Subclinical inflammation
Subclinical inflammation is a characteristic of obesity 47, 48 and may correlate with components of the metabolic syndrome. 3, 49, 50 Subclinical inflammation also correlates with markers of oxidative stress, 51 and may be a mechanism of obesity-associated insulin resistance and the metabolic syndrome. 52 Dietary antioxidants can influence the expression of proinflammatory cytokines and decreased antioxidant vitamin levels and reduced antioxidant capacity that are common in obese children. [53] [54] [55] A recent study investigated whether dietary fat and/or antioxidant intakes influence circulating tumor necrosis factor (TNF)-a, interleukin-6 (IL-6), C-reactive protein (CRP) and leptin concentrations in 6-14-year-old normal and overweight Swiss children. 56 There was a significant increase in CRP, IL-6
and leptin (Po0.02), but not TNF-a, with increasing adiposity, independent of age. Total dietary fat and percentage of energy from fat were significant predictors of CRP concentration, independently of BMI (Po0.05). Intakes of antioxidant vitamins (vitamins E and C and b-carotene) were significant predictors of leptin (Po0.05), but not CRP, IL-6 or TNF-a. These findings indicate that increased inflammatory markers are present in overweight children as young as 6 years. Intakes of total fat and antioxidant vitamins are determinants of subclinical inflammation in this age group. Although data from younger children are scarce, and most studies measured only CRP, 11, 49, 50, 57 these findings are consistent with earlier studies showing an increased subclinical inflammation in obese prepubertal children. 3 Some studies have found an increased circulating TNF-a in obese children, 58, 59 whereas others have not. 60 It appears that TNF-a acts primarily through its transmembrane form in an autocrine/paracrine manner in adipocytes. 47, 61, 62 Thus, although TNF-a expression is increased in adipose tissue, circulating TNF-a in obese animals and humans is often not detectable or only mildly elevated. 62 Although dietary studies in obese children have focused mainly on the metabolic syndrome and dyslipidemia, 63, 64 diet may also modulate the association between adiposity and subclinical inflammation. [65] [66] [67] Differences in total fat intake and specific fatty acids can modulate the inflammatory response. 65, 68 High concentrations of plasma-free fatty acidsFbecause of high fat intake and/or increased lipolysisFare found in overweight adults with the metabolic syndrome. 69 High levels of free fatty acids impair glucose and lipid metabolism 69 and induce the expression of proinflammatory cytokines in adipocytes, but this may not be a generalized effect of all fatty acids. Palmitate, but not laurate or docosahexanoic acid (DHA), induces IL-6 in adipocytes, 70 skeletal muscle cells 71 and endothelial cells. 72 Palmitate, but not other plasma-free fatty acids, correlates in vivo with IL-6 concentrations, independent of body fat mass. 72 Conjugated linoleic acid (linoleic acid (C18:2) with a conjugated double bond) may also increases the production of IL-6 and other proinflammatory cytokines in adipose tissue. 73 In contrast, n-3 PUFAs may ameliorate the inflammatory response. 74, 75 Supplementation with n-3 PUFAs modified phospholipid fatty acid composition and decreased the production of TNF-a and IL-6 by monocytes 76 when compared with palmitic acid. 77 Diets that are high in alinolenic acid (18:3n-3) tend to reduce inflammation. [78] [79] [80] In dyslipidemic adults, daily supplementation with a-linolenic acid for 3 months decreased concentrations of CRP and IL-6 by 38 and 11%, respectively.
81
Overweight adolescents with increased CRP and IL-6 concentrations have higher plasma saturated fatty acids and lower n-3 PUFAs compared with normal weight control participants. 82 It has been suggested that high dietary intake of specific fatty acids may stimulate IL-6 secretion, and, in contrast, high intakes of n-3 PUFAs may inhibit low-grade inflammation. 82, 83 However, in the Swiss study, 56 total fat intake and percentage of energy from fat, and not specific types of dietary fat, predicted subclinical inflammation, independently of BMI.
Oxidative stress may play a central role in the pathogenesis of various disease states, including diabetes and insulin resistance. 84, 85 Obesity per se may induce systemic oxidative stress 52 that may contribute to the dysregulation of adipocytokines and the development of metabolic syndrome. 86, 87 In obese adults, subclinical inflammation correlates with markers of oxidative stress 51 and CRP levels predict 8-isoPGF2a excretion independently of insulin and leptin levels. 88 Obesity in adults may be associated with lower levels of a-tocopherol and b-carotene.
51,89
Decreased antioxidant vitamin levels and reduced antioxidant capacity also appear to be characteristic of obese children. [90] [91] [92] In prepubertal obese children, vitamin E levels are significantly decreased and malondialdehyde levels are significantly increased compared with normal weight children, and these abnormalities are improved by a dietary restriction weight loss program. 93 In 6-19-year-old children in the National Health and Nutrition Examination Survey III, reduced serum levels of a-tocopherol and b-carotene were present in obese children. 55 However, in the National Health and Nutrition Examination Survey III, there were no significant differences in intake of b-carotene, a-tocopherol, fruit or vegetables between obese and non-obese children, as assessed by 24-h dietary recall and food frequency questionnaires.
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CRP is significantly associated with adiposity and components of the metabolic syndrome in adults. 57, [94] [95] [96] [97] CRP is also a predictor of insulin resistance in adults, 96, 97 but the relationship is variably attenuated after adjustment for adiposity. 94, 95 In children, data are more limited, but CRP has also been correlated with components of the metabolic syndrome. 11, 49, 50, 57, 98 However, studies suggest that increases in CRP, independent of adiposity, are associated with dyslipidemia but are not strongly associated with other components of the metabolic syndrome in children.
In adults, stronger associations between adiposity and CRP have been reported for women compared with men. 99 In children, the data are unclear. In Quebec, CRP concentrations were higher in 9-and 16-year-old girls than in boys at the same age. 50 In UK children aged 9-11 years, CRP concentrations were 47% higher in girls than in boys. 49 In adolescents in the 1999-2000 US National Health and Nutrition Examination Survey, women had higher CRP concentrations than men only at 16-19 years of age. 98 In contrast, CRP concentrations were similar by sex in a study in children in Taipei. 100 
Retinol-binding protein 4
Retinol-binding protein (RBP) 4 is a recently discovered adipokine that, in mice, increases insulin resistance in muscle and hepatic gluconeogenesis. 101 In humans, serum RBP4 concentrations may be correlated with obesity and insulin resistance. [102] [103] [104] RBP4 is the specific transport protein for serum retinol (SR), and alterations of retinol intake and vitamin A status affect hepatic release of RBP4 and circulating RBP4. 105 In addition, increased subclinical inflammation is a characteristic of obesity and RBP4 is a negative acute-phase protein. A recent Swiss study BF% and W/H ratio were significant predictors of RBP4, SR and RBP4/SR. Independent of adiposity, RBP4 and RBP4/SR were significantly correlated with serum triglycerides, and RBP4/SR was correlated with fasting insulin. The RBP4/SR ratio was more strongly correlated with components of the metabolic syndrome than with serum RBP4. This study showed that independent of subclinical inflammation, serum RBP4 and the RBP4/SR ratio are correlated with obesity, central obesity and components of the metabolic syndrome in prepubertal and early pubertal children. Circulating RBP4 concentrations are elevated in several mouse models of obesity and insulin resistance, and deleting the RBP4 gene in mice increases insulin sensitivity. 101 The link between RBP4 and insulin resistance in human crosssectional studies is less clear. Earlier studies in adults have reported significant associations between RBP4, obesity, and the metabolic syndrome. 102,107-109 Graham et al. 107 found serum RBP4 concentrations correlated with insulin resistance in participants with obesity, impaired glucose tolerance or type 2 diabetes. In contrast, other studies have not found a link between RBP and obesity and/or insulin resistance in adults. 110, 111 For example, Janke et al.
104
reported no differences in serum RBP4 among normal, overweight and obese women, and found RBP4 mRNA was downregulated in adipose tissue of obese women. Studies performed before RBP4 were identified as an adipokine investigated vitamin A status in adults with type 2 diabetes and reported equivocal results. [112] [113] [114] Two recent studies in adolescents reported increased RBP4 concentrations with increasing adiposity. In Korean adolescents, Lee et al.
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found an association between RBP4 and insulin resistance and serum triglycerides in non-obese adolescents, and between RBP4 and triglycerides in obese adolescents. Balagopal et al. 116 found that RBP4 was positively correlated with serum CRP concentrations. Although RBP4 is a negative acute-phase protein, 117 nearly all earlier studies did not assess the potential confounding of RBP4 by subclinical inflammation, a common finding in obesity. 117, 118 In the Swiss study, 106 although indices of inflammation were increased in the obese children, they were not correlated with RBP4, suggesting that subclinical inflammation is not a confounder in this age group. These data differ from those of Balagopal et al., 116 in which CRP is correlated with RBP4 in adolescents, a difference that may have been owing to differences in age and/or pubertal stage. RBP4 is mainly synthesized by the liver, bound to retinol and transthyretin 105, 119, 120 and its function is to transport retinol from hepatic storage to target tissues. However, not all serum RBP is bound to retinol, and the proportion that is not (apo-RBP) varies, as the binding of RBP to retinol and transthyretin is affected by multiple factors, including vitamin A status, the acute-phase response, protein-energy malnutrition, liver disease and renal failure. [121] [122] [123] [124] The RBP4-SR relationship may be important in obesity in that the link between RBP4 and insulin resistance may occur through retinol-dependent (that is, changes in retinol metabolism or delivery) or retinol-independent mechanisms. Retinoids can stimulate phosphoenolpyruvate carboxykinase expression in the liver and hepatic gluconeogenesis. In addition, retinol is a precursor for the synthesis of ligands of the retinoic acid receptor (RAR) and retinoid X receptor (RXR) nuclear receptors; 125, 126 these are partners of the peroxisome proliferator-activated receptor family that regulate genes central to fatty acid metabolism. 127 RBP4 could thus be linked to insulin resistance through impaired fatty acid metabolism, 128 and expression of several retinoidresponsive genesFRAR 2, stearoyl-CoA desaturase-1 and acetyl CoA carboxylaseFis increased in the muscle of RBP4-Tg mice. 101 Thus, increased delivery of retinol by RBP4 might explain its effects on insulin metabolism. However, the link between retinoids and insulin action is complex; some retinoids activate the RXR-peroxisome proliferator-activated receptor heterodimer and increase the insulin sensitivity, 128 whereas others produce insulin resistance in humans. 129, 130 Yang et al. 101 showed that RBP4 itself stimulates phosphoenolpyruvate carboxykinase expression and glucose production in cell cultures, which suggests the peptide has a direct, retinol-independent, effect.
LDL particle size
High intakes of free fructose (not derived from sucrose) may contribute to hypertension, dyslipidemia and obesity. 131, 132 In western Europe, unlike in the United States, high fructose corn syrup is not a commonly used sweetener. Thus, the origin of most free dietary fructose is fruits and vegetables and overall fructose intakes are lower than in the United States. Little is known about the metabolic effects of low-tomoderate levels of free fructose intake, particularly in children. Decreased low-density lipoprotein (LDL) particle size is associated with the metabolic syndrome and may be an early-onset risk factor for atherosclerosis and type 2 diabetes. 133 A recent Swiss study investigated the interrelationships between dietary intakes, and specifically, fructose consumption, and obesity, distribution of body fat, plasma lipids and LDL particle size. 134 Compared with the normal weight group, overweight children had significantly higher plasma triglyceride concentrations, lower HDL cholesterol concentrations and decreased LDL particle size (Po0.05). LDL particle size was inversely correlated to BMI-SDS (BMI standard deviation scores) and W/H ratio (P ¼ 0.007; P ¼ 0.002 and Po0.001, respectively). Overweight children consumed a significantly higher percentage of fructose from sweets and sweetened drinks (Po0.05). Controlling for adiposity, the only dietary factors that were significant predictors of LDL particle size were total fructose intake (P ¼ 0.024) and fructose/1000 kcal (P ¼ 0.042). The median fructose consumption in the Swiss study 134 ), corresponding to approximately 0.5% of daily energy intake. This is E20 times lower than mean intakes in the United States, in which approximately 9% of daily energy is derived from fructose. 135 High intakes of fructose have been implicated in the development of dyslipidemia and obesity. 131, 136 High intakes of dietary fructose induce hyperlipidemia in rodents, 132 but studies on the effect of fructose intake on plasma lipids in adult humans are equivocal. Several have shown an effect of a high fructose intake on plasma lipids, particularly increased triglyceride concentrations, 137,138 but others have not. 135, 139 The dietary determinants of LDL particle size in adults and children are uncertain. Several studies have shown that short-term high carbohydrate diets lead to a reduction in LDL particle size, 140-142 but they investigated only total carbohydrate intake and not specific types of carbohydrates. In the Swiss study, 134 fructose intakes were correlated with LDL particle size but not with adiposity or any other lipid parameter in the study children. This suggests one of the earliest metabolic effects of higher fructose intake may be modulation of LDL particle size. This finding is consistent with an earlier study in adults with coronary artery disease, 143 in which changes in LDL particle size appeared to precede other dyslipidemic changes.
